Omega-3

The new technology, plus a new algal variation, will be introduced at Expo West 2025.

This study builds on previous animal research that found the lipid emulsion made from Ahiflower was associated with significantly lower inflammation, improved insulin sensitivity, and improved gut microbiota, compared to that of soybean oil or fish oil.

The study compared muscle recovery after injury in rats with and without fish oil supplementation in their diets.

Recent study evaluated the association between plasma omega-3 levels and risk of heart failure

The algal EPA+DHA ingredient expands on the company's existing algal omega-3 portfolio which was DHA only.

CoreFX's showcased its recently announced CoreNhanced optimized delivery platform.

The Global Organization for EPA and DHA Omega-3s’ vice president of regulatory and scientific affairs talks about recent class actions and why they are without merit.

At SupplySide West 2024, Solutex will exhibit product offerings, as well as celebrate their 20th anniversary.

According to the company’s announcement, the AI platform is able to identify real-time deviations or anomalies in GC Rieber VivoMega’s processing facilities and report them via a cloud-based, comprehensive, centralized system.

Results showed that both doses of krill oil significantly reduced TEWL, and increased hydration as well as elasticity compared to placebo.

SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.

The Canadian companies have joined forces to create more cost-effective and bioavailable fortification of plant-based omega-3s.

A recently published study found that Ahiflower oil from the seeds of Buglossoides arvensis may improve plasma eicosapentaenoic acid (EPA) levels.

A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.

The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.

Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.

According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.

The $75 million facility expansion allows the company to double its output of the triglyceride form of marine omega-3s EPA and DHA and certified vegan EPA & DHA algal oils.

The researchers concluded that fish oil supplementation by healthy people may actually put them at risk of developing atrial fibrillation and stroke, while offering a benefit to those diagnosed with cardiovascular disease by reducing their risk of experiencing major adverse cardiovascular events.

The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.

The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.

At-home testing and wearable tech will put supplements to the test as consumers measure and track their cardiovascular, liver, and blood sugar health.

GC Rieber VivoMega has announced that its three omega-3 facilities are running on 100% renewable energy after having implemented an electric steam boiler to power its marine and microalgae omega-3 operations.

At this year’s Natural Products Expo West, two brands have launched their own versions of algae DHA ingredients; FrieslandCampina and Aker BioMarine. Each brand showcased a different approach to the ingredient.

Nutritional Outlook talks to Matts Johansen, CEO of Aker BioMarine, about the company's new algae DHA ingredient, FloraMarine.

A look at marine plants and how to sustainably harvest and process them.

The company states that the oil delivers 60% DHA.

In the study, supplementation alone did not have a significant impact on cardiovascular outcomes in patients who've recovered from mycocardial infarction. However, subjects taking omega-3s that had a 5% increase in omega-3 index did see better health outcomes than those who did not.

FrieslandCampina Ingredients has announced the launch of two algae-based DHA ingredients: Biotis DHA FlexP 15 and Biotis DHA FlexP 20.

GOED announces new chair, vice-chair, and secretary.